184 related articles for article (PubMed ID: 17553361)
1. [Prostate cancer--incidence and risk factors].
Brasso K
Ugeskr Laeger; 2007 May; 169(20):1883-6. PubMed ID: 17553361
[TBL] [Abstract][Full Text] [Related]
2. [Cancer of the prostate. 1. Epidemiology].
Mottet Auselo N; Costa P; Le Pellec L; Louis JF; Navratil H
Prog Urol; 1995 Feb; 5(1):31-7. PubMed ID: 7536526
[TBL] [Abstract][Full Text] [Related]
3. A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk.
Gsur A; Preyer M; Haidinger G; Schatzl G; Madersbacher S; Marberger M; Vutuc C; Micksche M
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):497-8. PubMed ID: 12010866
[No Abstract] [Full Text] [Related]
4. Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia.
Lagiou A; Samoli E; Georgila C; Minaki P; Barbouni A; Tzonou A; Trichopoulos D; Lagiou P
Eur J Cancer Prev; 2008 Aug; 17(4):336-9. PubMed ID: 18562958
[TBL] [Abstract][Full Text] [Related]
5. Progensa PCA3 test for prostate cancer detection.
de la Taille A
Expert Rev Mol Diagn; 2007 Sep; 7(5):491-7. PubMed ID: 17892357
[TBL] [Abstract][Full Text] [Related]
6. [Risk factors of prostatic cancer].
Friis S; Kjaer SK; Storm HH
Ugeskr Laeger; 1994 Jun; 156(23):3485-90. PubMed ID: 8066864
[TBL] [Abstract][Full Text] [Related]
7. Birth characteristics and risk of prostate cancer: the contribution of genetic factors.
Cnattingius S; Lundberg F; Sandin S; Grönberg H; Iliadou A
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2422-6. PubMed ID: 19690187
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for low trauma fractures in men with prostate cancer.
Ahlborg HG; Nguyen ND; Center JR; Eisman JA; Nguyen TV
Bone; 2008 Sep; 43(3):556-60. PubMed ID: 18585119
[TBL] [Abstract][Full Text] [Related]
9. Incidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screening.
Lee UJ; Jones JS
Prostate Cancer Prostatic Dis; 2009; 12(1):52-6. PubMed ID: 18504455
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer and schizophrenia.
Torrey EF
Urology; 2006 Dec; 68(6):1280-3. PubMed ID: 17141844
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
12. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
Huo D; Hetzel JT; Roy H; Rubin DT
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1979-85. PubMed ID: 19531678
[TBL] [Abstract][Full Text] [Related]
13. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
[TBL] [Abstract][Full Text] [Related]
14. Statins and the risk of prostate cancer or benign prostatic hyperplasia: biological plausibility.
Getzenberg RH
J Urol; 2010 Aug; 184(2):415-6. PubMed ID: 20620390
[No Abstract] [Full Text] [Related]
15. Prostate cancer: 3. Individual risk factors.
Gallagher RP; Fleshner N
CMAJ; 1998 Oct; 159(7):807-13. PubMed ID: 9805030
[No Abstract] [Full Text] [Related]
16. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.
Roobol MJ; Grenabo A; Schröder FH; Hugosson J
J Natl Cancer Inst; 2007 Sep; 99(17):1296-303. PubMed ID: 17728218
[TBL] [Abstract][Full Text] [Related]
17. The role of testosterone in the pathogenesis of prostate cancer.
Imamoto T; Suzuki H; Yano M; Kawamura K; Kamiya N; Araki K; Komiya A; Nihei N; Naya Y; Ichikawa T
Int J Urol; 2008 Jun; 15(6):472-80. PubMed ID: 18430151
[TBL] [Abstract][Full Text] [Related]
18. Prostate disease prevalence with epidemiological and hormonal analysis in randomly selected male population in Croatia.
Galić J; Simunović D
Coll Antropol; 2008 Dec; 32(4):1195-202. PubMed ID: 19149228
[TBL] [Abstract][Full Text] [Related]
19. Incidence and factors predicting the detection of prostate cancer after transurethral resection of the prostate for clinically benign disease.
Bright EA; Manuel C; Goddard JC; Khan MA
Urol Int; 2009; 83(2):171-4. PubMed ID: 19752612
[TBL] [Abstract][Full Text] [Related]
20. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
Zhigang Z; Wenlu S
Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
